Embed Size (px)
Citation preview
COVID-19 Vaccine: 5 through 11 yearsVermont Department of Health –November 09, 2021
Merideth Plumpton, RN - Nurse Program CoordinatorMeghan Knowles, MS - Communication and Training Coordinator
Agenda
• ACIP Recommendations• Vermont Implementation• Ordering and Inventory Management• Storage and Handling• Administration• Clinic Planning• Communication with Parents• Additional Resources• Q+A
2Vermont Department of Health
5 through 11 - ACIP Recommendations
3Vermont Department of Health
ACIP Recommendations
The Pfizer-BioNTech COVID-19 vaccine (2 doses, 10µg, IM) is recommended for children 5 through 11 years of age in the U.S. population under an Emergency Use Authorization.
This applies to all children 5-11, including those with underlying conditions and previous COVID infection.
See the clinical considerations presentation with important details on implementation and administration language for this pediatric population as reviewed by the committee.
ACIP November 2-3, 2021 Presentation Slides | Immunization Practices | CDC
4Vermont Department of Health
Safety and Efficacy Summary
• ~3,000 children vaccinated with the Pfizer vaccine during clinical trials • 90.7% effective against symptomatic COVID disease• no deaths, no case of myocarditis, no Bell’s palsy, and no anaphylaxis. • There have been 0 deaths related to myocarditis from the COVID-19 vaccine in
adolescents and adults, a statistic many voting members felt compelling when deciding their vote.
• Systemic and local reactions were less severe in the 5-11 cohort compared to older children and adolescents.
The committee felt that the safety and efficacy data were clear, and that benefits overwhelmingly outweigh the risks of COVID disease (ie. MIS-C, unknown effects of long term COVID, etc.)
5Vermont Department of Health
Schedule and timing
• Administered intramuscularly as a primary series of 2 doses (0.2 mL each) 3 weeks apart to individuals 5 through 11 years of age.
• The 4-day grace period applies to this formulation.• There is no maximum interval between doses. Regardless of length of time
since 1st dose, no need to restart series. • For those who age from 11 to 12 years old, mid series:
• While both formulations are allowed under their EUA, CDC recommends giving patients the dose based on their age at the time of vaccination. Doing otherwise, however, would not be considered an error.
• No recommendations for an additional dose for an immunocompromised child.
• No booster recommendation for this age group.
6Vermont Department of Health
Side effects for 12 though 15 vs. 5 though 11 age group
(30 mcg modRNA) in adolescents 12 through 15 years of age
• pain at the injection site (90.5%), • fatigue (77.5%), • headache (75.5%), • chills (49.2%), • muscle pain (42.2%), • fever (24.3%), • joint pain (20.2%), • injection site swelling (9.2%), • injection site redness (8.6%), • lymphadenopathy (0.8%),• nausea (0.4%).
7Vermont Department of Health Home | CVDvaccine-US.com
(10 mcg modRNA) in children 5 through 11 years of age
• pain at the injection site (84.3%), • fatigue (51.7%), • headache (38.2%), • chills (12.4%), • muscle pain (17.5%), • fever (8.3%), • joint pain (7.6%), • injection site swelling (20.4%), • injection site redness (26.4%), • lymphadenopathy (0.9%),• nausea (0.4%).
5 through 11 – Vermont Implementation
8Vermont Department of Health
Vermont Implementation
• Initial allocation of 15,900 doses prepositioned across the state for school and community clinics.
• Vermont has a proven track record of effectively using large community clinics for rapid vaccine distribution.
• Opened registration for school based and community clinics on 11/3. Almost 16,000 kids have registered so far.
• Many pharmacies received their allocation of pediatric vaccine this week.
9Vermont Department of Health
Current landscape
Demand and capacity to vaccinate far exceeds supply.
• Uptake at community clinics has exceeded the states expectations.• Almost 16,000 have registered for state-run community and school located clinics. This is more than a
3rd of the state's population of 5 through 11-year-olds.• Due to this high uptake, the state is obligated to fulfill all those second dose needs.• We are asking for additional vaccine at the highest levels, but this is not a simple or quick
process.• At this time, we do not have enough vaccine to support routine ordering for PCP offices.• Large community clinics are the fastest way to get your patients vaccinated. Please refer kids
that can get vaccinated at a pharmacy or community clinic to the state website. There they will be able to sign up via the state system and see which pharmacies are offering vaccine in their area. https://www.healthvermont.gov/covid-19/vaccine/vaccines-children
10Vermont Department of Health
State-wide Clinic schedules
• COVID-19 Vaccines for Children | Vermont Department of Health contains an interactive map showing both vaccine clinics and pharmacies.
• Getting the Vaccine > Vaccine Clinics has a clinic list organized by town
• School-Based Vaccination Clinics | Agency of Education – shows school-located clinics by county
• Vermont registration site OR• Call the Health Department to register | 855-
722-7878, Mon - Fri 8:15 am - 4:30 pm, Sat and Sun 10:00 am - 3:00 pm
11Vermont Department of Health
Data driven decisions
• We are using IMR, registration data, and geographic distribution to assist with internal decision making.
• As your patients continue to get vaccinated at community clinics, utilize the IMR reporting tools to help inform outreach and vaccine need. • Patients who have NOT received any COVID-19 doses | VDH IMR:• Patients who have missed/are late for a second COVID-19 dose | VDH IMR:• Patients who HAVE received a COVID-19 dose | VDH IMR:
12Vermont Department of Health
5 through 11 – Ordering and Inventory Management
13Vermont Department of Health
First Pediatric Pfizer Order
• Tonight (11/09), Pediatric Pfizer vaccine will be made available in your VIMS catalog. • To the best of your ability, determine the number of doses you can use as FIRST DOSES
in 2 weeks (administration between approx. 11/17 and 12/01). Place an order for this amount tomorrow November 10, as a COVID-19 Only Order from the VDH DEPOT.• Even if you determine the minimum order (100 doses) or more is needed for this time frame, do NOT
place a direct order. We may not be able to fulfill your need this first week, and initial orders may all come from the Depot.
• Second dose needs are being taken into consideration when planning. Do not hold doses. • Confirmation for delivery quantity, and delivery date (between 11/15 and 11/18), will go out from the
[email protected] email no later than Thursday night. Expect changes to requested order quantity. Do not expect all two weeks of vaccine next week.
• Guidance may change before the next order date (11/17), so please be mindful of our communications.
14Vermont Department of Health
Health Care Partners and Umbrella organizations
• Some Healthcare partners participating in community vaccination efforts currently have pediatric vaccine available. Please refer to communication through the [email protected] today and tomorrow for up-to-date guidance.
• If you are receiving a transfer from your umbrella organization, you will not place an order in VIMS and should work through your organization.
15Vermont Department of Health
COVID-19 Vaccine ordering, general reminders
• Do not order other routine vaccines on Wednesdays, reserve for COVID-19 orders.
• VIMS COVID-19 reconciliation must happen every Wednesday, even if you do not intend to order.• Adjust out doses first, such as waste before completing a “COVID-19-Only Reconciliation”
• After reconciling on Wednesday, practices may place an order for direct delivery or as a transfer from the depot. Wednesdays are the cut off for all COVID-19 orders. Delivery will occur the following week. • Do not adjust doses into your inventory. Orders and Depot transfers will populate into your
inventory automatically by the end of day. If transferring out, enter into VIMS on the same day it occurs.
• If you receive vaccine transfers from your umbrella organization, you will not place an order in VIMS and should work through your organization.
16Vermont Department of Health
Distributor or Depot Delivery?
• The Health Department preference is to utilize distributor deliveries as much as possible. • COVID-19 vaccine ships directly to you via FedEx or UPS, from McKesson (for Moderna and
Janssen) and Pfizer, just like routine vaccines. No set delivery date but tracking info will be available in VIMS.
• Ancillary supplies arrive in separate packaging within a day or two of the vaccine delivery. • Minimum order quantities apply.
• When clinic planning, order minimums, storage, or other concerns prevent a distributor delivery, Vermont utilizes its vaccine Depot. • The Depot delivers vaccine and ancillary supplies to sites needing less than the minimum order
quantities. • Because the Depot has limited resources, deliveries for the week following a Wednesday order are
batched together geographically. You will get verification of the delivery date by e-mail. • When vaccine is not in limited supply a three-week order is preferred to limit the number of
deliveries. 17Vermont Department of Health
COVID-only order from Distributor
Vermont Department of Health
• Orders must be placed in quantities of:• Pfizer 12+: 1170 doses (195 vials)• Pfizer 5-11: 100 doses (10 vials)• Moderna: 140 doses (10 vials) • Janssen 100 doses (20 vials)
• Orders must be submitted on Wednesdays• Confirmation E-mail is sent from
[email protected] no later than Thursday evening.
• Tracking information is available in VIMS.• Ancillary supplies will arrive in separate packaging
Direct shipments from the Distributor require:
COVID-only order from VDH Depot
19Vermont Department of Health
• Ordering from VDH depot means vaccine is delivered to your practice as a transfer from the Health Dept depot.
• Order quantity in multiples of:•Pfizer 12+: 6 doses•Pfizer 5-11: 10 doses•Moderna: 14 doses • Janssen 5 doses
• Orders must be submitted on Wednesdays• Confirmation E-mail is sent from
[email protected] no later than Thursday evening including the planned date of delivery
• Delivery includes all ancillary supplies
Submitting a mixed Depot and Distributor Order
20Vermont Department of Health
• VIMS will not allow both a Depot and Distributor order at the same time. • If all the products you order don’t meet the required minimums, submit everything as a Depot
order. During the approval process we will update all qualifying orders to Distributor.• This will be reflected on the e-mail you receive the Thursday following your order.
• Generally, please submit orders from the distributor if possible.• When ordering in multiples of the minimum quantities: Pfizer 12+: 1170 doses (195 vials) | Pfizer
5-11: 100 doses (10 vials) | Moderna: 140 doses (10 vials) | Janssen 100 doses (20 vials)• If close to the minimum quantity, round up• When you require fewer than the minimum, submit as a Depot order.
Ancillary Supplies
21Vermont Department of Health
• If direct shipment, ancillary supplies will come from McKesson, separate from the vaccine.• For issues with your ancillary supplies, contact McKesson Customer Service at 1-833-272-6634,
or via email [email protected].• If Depot transfer, ancillary supplies will come with the vaccine transfer.
• For issues with ancillary supplies, contact [email protected]
5 through 11 – Pfizer Storage and Handling
22Vermont Department of Health
Accepting a direct shipment
23Vermont Department of Health
• Container can not be used for temporary storage.
• Unpack as soon as possible upon receipt and put vaccine in appropriate storage (Refrigerator or Ultra Cold ONLY)
• The single-use shipper and dry ice should be disposed of.
• The Controlant temperature monitoring device will need to be returned.
Accepting a shipment - what’s in the box
24Vermont Department of Health
Accepting a direct shipment - Unpacking
• Thermal shipper contains dry ice. Have goggles and waterproof insulated gloves available (rubber garden gloves will be sufficient).
• Unpack container according to instructions that come with shipper.
• Place vaccine into ultra cold freezer or refrigerator only. • Pfizer 5 though 11 COVID-19 vaccine can not be stored at regular
freezer temperatures!• If placing vaccine in the refrigerator mark with beyond use date.
• Discard dry ice in well ventilated area.
• Return the temperature monitoring device using the temperature monitoring return kit included in your thermal shipper.
• Dispose of single use thermal shipping container.
25Vermont Department of Health
26Vermont Department of Health
Deliveries from the Vaccine Depot
• Vaccine will arrive at refrigerated temperatures.• Vaccine must be placed in refrigerator at time of delivery. • Vaccine will be labeled with beyond use date.• Ancillary supplies will arrive with the vaccine.
27Vermont Department of Health
Pediatric Pfizer Storage and Handling
• Vials are labeled with manufacture date and not expiration date.
• Vials are good for up to 6 months after manufacture date in ultra cold freezer.
• Once refrigerated, vials can be stored for up to 10 weeks. The 10-week refrigerated beyond use date should be recorded on the carton at the time the vaccine is placed in the refrigerator.
• May be stored at 8°C to 25°C (46°F to 77°F) for a total of 12 hours prior to dilution.
• After dilution, the vial should be held between 2ºC to 25°C (35°F to 77°F). Vials should be discarded 12 hours after dilution.
28Vermont Department of Health
Vial labels and cartons may indicate that a vial should be discarded 6 hours after the first puncture. The information in the Fact Sheet supersedes the number of hours printed on vial labels and cartons.
Orange (5-11) vs. Purple (12+) – Storage Conditions
29Vermont Department of Health
Beyond Use Date/Time
Expiration Date• Associated with a specific lot number and might be extended as new data is obtained.• Change is reflected in VIMS and communicated by the Immunization Program.• NOTE: The date reflected on the Pfizer pediatric vial is the Manufacture date. NOT the expiration.
Add 6 months to this date.
Beyond Use Date• When Pfizer vaccine is moved out of ultracold freezer storage and into refrigerated temperatures, it
has a Beyond Use Date that should be documented clearly.• Tracking and adherence to a Beyond Use Date is the practice's responsibility and will not
be reflected in VIMS.
Beyond Use Time• All COVID-19 vaccines have Beyond Use Times associated with dilution/vial puncture, after which
the vaccine must be disposed of.30Vermont Department of Health
5 through 11 – Administration
31Vermont Department of Health
Pfizer 5-11 COVID Vaccine Specifics
32Vermont Department of Health
Administration - Overview
The Pfizer BioNTech Vaccine is administered IM as a primary series 2 doses (0.2mL each) 3 weeks apart in those 5 through 11 years of age.
• Invert vial gently 10 times to mix (do not shake)• May contain white to off white particles
• Dilute vaccine, by adding 1.3ml sterile 0.9% Sodium Chloride• ONLY use diluent that comes with vaccine, do not substitute
• Equalize pressure in vial by removing 1.3ml air• Invert vial 10 times to mix, (do not shake)• Record the date and time you punctured the vial for dilution
• Store at refrigerated temperatures• Discard any unused vaccine 12 hours after dilution
• Draw 0.2ml of vaccine for IM injection. Use the low dead volume 1ml syringes that come in your ancillary kit to draw the vaccine.
33Vermont Department of Health
Administration - Dilution
34Vermont Department of Health
• Verify that the vial has an Orange cap and label border and states “Age 5y to<12y”
• Do NOT use vaccine intended for 12 years and older (Purple Cap) for individuals 5 through 11 years.
• Dilute vaccine only with the diluent provided (sterile 0.9% Sodium Chloride)
• After dilution with 1.3mL of diluent, the vial will contain 9-10 doses at 0.2mL.
• Do NOT add more than 1.3mL of diluent.
Regardless of the volume remaining in the diluent vial, it must be used for a ONE-TIME dilution. After 1.3mL withdrawal, the remaining diluent must be discarded.
Orange (5-11) vs. Purple (12+) – Administration
35Vermont Department of Health
Administration – Tips
• Do NOT pool vaccine from multiple vials to make a full dose.• Pedi Pfizer ancillary kits contain 1” needles. CDC is not sending any 5/8” needles in the
pediatric ancillary kits. See Administering Vaccines: Dose, Route, Site, and Needle Sizefor more information.
• COVID-19 vaccines may be administered without regard to timing of other vaccines.• This includes simultaneous administration of COVID-19 vaccine and other vaccines on the same day.• See CDC Best practices for more information on coadministration of vaccines.
• No additional doses or boosters have been approved for 5 though 11.• Give the Pfizer vaccines based on age at the time of administration.
• For those who age 11 to 12 mid series, either vaccine is allowed under the EUA.• CDC recommends giving them the dose based on their age at the time of vaccination. • Doing otherwise is not considered an error.
36Vermont Department of Health
5 through 11 – Clinic Planning
37Vermont Department of Health
Planning to use Pediatric COVID-19
• Your office may plan to use the pediatric COVID-19 vaccine through:• Regularly scheduled appointments• A COVID-19 vaccine clinic for your patients• An offsite clinic for community members
• Planning larger clinics will be challenging in the first several weeks while the state is under allocation and must continue providing vaccine for community clinics and second dose needs.
• We recommend prioritizing your children and youth with special health needs (CYSHN) patients in the early administration of your pediatric vaccine.
• When vaccine is available to you, please consider coadministration with other pediatric vaccines and flu.
• Vials have 9-10 doses, must be used within 12 hours of puncture.• Waste guidance has not changed. Be thoughtful with planning, but do not turn anyone away.• 15 to 30-minute observation time post vaccination.
38Vermont Department of Health
Grant Funding is Available
The American Academy of Pediatrics Vermont Chapter, in collaboration with the Vermont Department of Health’s Immunization Program, is providing funding to support expanded influenza and/or COVID vaccination by healthcare practitioners or organizations.
• Health Care Practices/Organizations may receive $1000 per clinic held (up to a maximum of $5000 total).
• Applications may include clinics held retrospectively starting September 1, 2021. • Applications will be reviewed on receipt, and funds will be distributed upon receipt of the
final project report. • Applications must be received by November 19, 2021. • Immunization clinics that are part of this grant must be held and reported on by March
31, 2022.
Visit www.aapvt.org for more information. Send completed the 2021-2022 Flu Grant Applications and questions to Stephanie Winters at [email protected].
39Vermont Department of Health
v-safe
V-Safe is a smartphone-based tool that uses text messaging and web surveys to give personalized health check-ins after you receive a COVID-19 vaccine. This information helps CDC monitor the safety of COVID-19 vaccines in near real time. • V-Safe, and CDC has created a v-safe poster that you may post in your
office or vaccination sites.
• V-Safe has a section to add on dependents. Enroll Your Dependent in v-safe | CDC
40Vermont Department of Health
5 through 11 –Communication with Parents / Guardians
41Vermont Department of Health
Resources on How to talk with Parents / Guardians
How to Talk with Parents about COVID-19 Vaccination | CDC
COVID-19 Vaccines for Children and Teens | CDC
COVID-19 Vaccine Authorized For Ages 5 to 11: What Parents Need to Know > News > Yale Medicine
Questions and Answers About COVID-19 Vaccines - Vaccinate Your Family
42Vermont Department of Health
National Town Hall on Children’s Vaccine for Parents
Reed Tuckson and The Black Coalition Against COVID hosted a Town Hall event which featured doctors answering parent questions about COVID vaccine, and AIM’s own Michele Roberts discussing the rollout. It was held last week. You can catch the recording and share it with others on Facebook or Youtube.
43Vermont Department of Health
Vermont Family Network – Confident Care for Kids
Vermont is launching an initiative to increase sensory supports for children with disabilities and special health needs to ease their anxiety while getting their COVID-19 vaccine.
Training will be offered on November 15 from 12:15-1:15. Register here.For questions, contact Jamie Rainville [email protected].
Participating practices will receive:• A one-hour virtual training for all providers and practice staff taught by the UVM
Children’s Hospital EmPower Team, therapists and families• One sensory tool kit filled with sensory items,• Rewards for children after the vaccine,• Tips for creating a sensory friendly environment, and• Gas cards for families who need the extra help in getting to the office.
Confident Care for Kids - Vermont Family Network – this site has many of the resources available through the training, as well as language and tips to share with parents or guardians prior to a vaccination visit.
44Vermont Department of Health
AAPVT Family Forums
In the Spring, when the EUA was approved for 12 and above, AAPVT held forums where parents could connect with local pediatricians to receive information and ask questions. AAPVT will hold these forums again for the EUA approval of 5 and above!
The goal is to have a meeting in each district with local pediatric clinicians. The AAPVT website has all currently scheduled sessions and will be updated as new sessions are confirmed. There is also a graphic for the conversations, which you can share with your patients.
45Vermont Department of Health
5 through 11 – Additional Resources
46Vermont Department of Health
CDC Resources
Pfizer-BioNTech COVID-19 Vaccine: Clinical Materials for Ages 5 through 11 yearsThe materials below are for the new Pfizer-BioNTech COVID-19 vaccine formulation for ages 5 through 11 years:
• Vaccine Standing Orders for Administering Vaccine to Persons 5 through 11 Years of Age• Vaccine Preparation and Administration Summary• Vaccine Storage and Handling Summary • Vaccine Storage and Handling labels • Beyond Use Date guidance and labels • Transporting Vaccine for Vaccination Clinics Held at Satellite, Temporary or Off-Site Locations
Administration Overview for Pfizer-BioNTech COVID-19 Vaccine | CDC Interim Clinical Considerations for Use of COVID-19 Vaccines | CDC
47Vermont Department of Health
COCA Training and ACIP Slide decks
Pediatric COVID-19 Vaccines: CDC’s Recommendations for Pfizer-BioNTech COVID-19 Vaccine Primary Series in Children 5–11 Years Old | November 4, 2021
The Centers for Disease Control and Prevention will provide an overview of its recommendations and clinical considerations for administering the Pfizer-BioNTech COVID-19 vaccination primary series in children aged 5–11 years old. Slides of the webinar are also available here.
ACIP November 2-3, 2021 Presentation Slides | Immunization Practices | CDC
48Vermont Department of Health
EUA’s an MMWR
EUA For Health Care Providers - 12 years and olderEUA For Heath Care Providers - 5 through 11 years
EUA For Recipients - 12 years and olderEUA For Recipients - 5 through 11 years
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years —United States, November 2021 | MMWR (cdc.gov)
49Vermont Department of Health
50Vermont Department of Health
Date & Time PasswordAttendee link – November 9 – 5 PM ET aRDjkmMD349
Attendee link – November 10 – 12 PM ET QPfX8RMy8M7
Attendee link – November 11 – 12 PM ET Tntjh4UMr55
Attendee link – November 12 – 12 PM ET mfP2vm8HhD5
Attendee link – November 15 – 5 PM ET SUeJ7teYc45
Attendee link – November 16 – 5 PM ET ZMjtfDdn438
Attendee link – November 17 – 12 PM ET YYkSGJGT848
Attendee link – November 18 – 12 PM ET 8ZGbRrha2f8
Attendee link – November 19 – 12 PM ET PzpX4ZPnT63
Attendee link – November 22 – 5 PM ET YKwPs6P85cH
Attendee link – November 23 – 5 PM ET S4wspGuhN33
Attendee link – November 24 – 12 PM ET iWpzpvHh667
Pfizer TrainingPfizer Vaccines US Medical Affairs continues to host daily Medical Updates & Immunization Site Training for All Providers with a Focus on Emergency Use Authorization of the Pfizer-BioNTech COVID-19 Vaccine for Children 5 through 11 Years of Age.
In addition to Medical Updates, sessions will focus on the Storage, Handling, & Administration for currently available vaccine presentations.
These sessions will be updated to reflect new information and changes that evolve. Such updates will be identified at the start of each session, and further explained during each presentation.
Please click on the links below to join the sessions at the designated times.*
Pfizer Vaccine Administration Codes
51Vermont Department of Health
Questions?
Vaccine Storage and Handling, Vaccine Specific InformationE-mail: [email protected]
Phone: 1-800-640-4374
Immunization Registry and ReportingE-mail: [email protected]: 1-888-688-4667
Vaccine Distributionwill send COVID-19 confirmation, send inquiries to main inbox
E-mail: [email protected]
Vermont Department of Health 53
Health Department Resources Linked in Presentation (1 of 2)
Temperature Excursion Protocol | VDH: https://www.healthvermont.gov/sites/default/files/documents/pdf/COVID19-Vaccine-Temp-Excursion-Protocol.pdf
COVID-19 Vaccine Storage and Handling for Off-site Clinics | VDH:https://www.healthvermont.gov/sites/default/files/documents/pdf/COVID19-Vaccine-Off-Site-Clinic-Guidance.pdf
Hourly Paper Temperature Log | VDH:https://www.healthvermont.gov/sites/default/files/documents/pdf/ID_IZ_INFOHCP_VCVPVAVP_Hourly%20Vaccine%20Temperature%20Log.pdf
Tracking Vaccine Inventory | VDH :https://www.healthvermont.gov/covid-19/health-care-professionals/vaccine-information-health-care-professionals
Minimizing Waste Policy | VDH :https://www.healthvermont.gov/sites/default/files/documents/pdf/COVID19-Vaccine-Minimize-Waste-Policy.pdf
Vermont Department of Health 54
Health Department Resources Linked in Presentation (2 of 2)
Patients who have NOT received any COVID-19 doses | VDH IMR:https://www.healthvermont.gov/sites/default/files/documents/pdf/IMR_Patient_List_By_DOB_%20Report_Guide-COVID-19.pdf
Patients who have missed/are late for a second COVID-19 dose | VDH IMR:https://www.healthvermont.gov/sites/default/files/documents/pdf/IMR_How%20to%20Use%20the%20Not%20Up%20To%20Date%20Report%20-COVID.pdf
Patients who HAVE received a COVID-19 dose | VDH IMR:https://www.healthvermont.gov/sites/default/files/documents/pdf/IMR_Patients_Immunized_By_Series_%20Report_Guide-COVID-19.pdf
Vaccine Information for Health Care Professionals | VDH:https://www.healthvermont.gov/covid-19/health-care-professionals/vaccine-information-health-care-professionals
Vermont Department of Health 55
Additional Health Department Resources
Vermont COVID-19 Vaccine Program Training Guidehttps://www.healthvermont.gov/sites/default/files/documents/pdf/COVID19-Vaccine-Training-Quick-Guide.pdf
State-Supplied Temperature Monitoring Resourceshttps://www.healthvermont.gov/immunizations-infectious-disease/immunization-health-care-professionals/vaccine-storage-and-handling
COVID-19 VIMS User Guidehttps://www.healthvermont.gov/sites/default/files/documents/pdf/COVID19-VIMS-Hospital-User-Guide.pdf
COVID-19 Only Reconciliation Guidehttps://www.healthvermont.gov/sites/default/files/documents/pdf/COVID19-VIMS-Reconcile-Quick-Guide.pdf
Vermont Department of Health 56
External Resources Linked in Presentation (1of 2)
Pre-vaccination Screening Form | CDC:https://www.cdc.gov/vaccines/covid-19/downloads/pre-vaccination-screening-form.pdf
COVID-19 Vaccine for Children | AAP:https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/covid-19-vaccine-for-children/
Interim Clinical Considerations for Use of COVID-19 Vaccines | CDC:https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html
Preparing for Potential Management of Anaphylaxis | CDC:https://www.cdc.gov/vaccines/covid-19/clinical-considerations/managing-anaphylaxis.html
COVID-19 Clinical Consultation | CDC:https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/cisa/index.html
Ask The Experts | Immunization Action Coalition:https://www.immunize.org/askexperts/experts_cov.asp
Vermont Department of Health 57
External Resources Linked in Presentation (2 of 2)
Provider Relief Fund | HRSA:https://www.hrsa.gov/coviduninsuredclaim
V-safe Print Resources | CDC:https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/vsafe/printresources.html
VAERS Video Instructions | YouTube:https://youtu.be/sbCWhcQADFE
COVID-19 Vaccinations | CDC:https://www.cdc.gov/vaccines/covid-19/
Vermont Department of Health 58
CDC Printable Resources
Summary Document for Interim Clinical Considerations Poster:https://www.cdc.gov/vaccines/covid-19/downloads/summary-interim-clinical-considerations-poster.pdf
COVID-19 Vaccine Administration Errors and Deviations Poster:https://www.cdc.gov/vaccines/covid-19/downloads/covid19-vaccine-errors-deviations-poster.pdf
CDC Vaccine Recipient Education
Vaccinate With Confidence:https://www.cdc.gov/vaccines/covid-19/vaccinate-with-confidence.html
Talking with Patients About COVID-19 Vaccine:https://www.cdc.gov/vaccines/covid-19/hcp/engaging-patients.html
Pediatric Healthcare Professionals Toolkit:https://www.cdc.gov/coronavirus/2019-ncov/vaccines/toolkits/pediatrician.html
Vermont Department of Health 59
Pfizer-BioNTech Resources
FDA Pfizer-BioNTech COVID-19 Vaccine Website - Includes Fact Sheets, FAQs, Regulatory information and translations:https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine
Manufacturer Website: https://www.cvdvaccine-us.com
CDC Website - full of vaccine specific tools and resources: https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/index.html
• Storage Summary:https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/downloads/storage-summary.pdf• Preparation Summary:https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/downloads/prep-and-admin-summary.pdf• Standing Orders: https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/downloads/standing-orders.pdf• Preparation Info Graphic:https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/downloads/storage-summary.pdf
Vermont Department of Health 60
Moderna Resources
FDA Moderna COVID-19 Vaccine Website - Includes Fact Sheets, FAQs, Regulatory information and translations:https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/moderna-covid-19-vaccine
Manufacturer Website: https://www.modernatx.com/covid19vaccine-eua/providers
CDC Website - full of vaccine specific tools and resources: https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/index.html
Storage Summary:https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/downloads/storage-summary.pdf
Preparation Summary:https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/downloads/prep-and-admin-summary.pdf
Standing Orders: https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/downloads/standing-orders.pdf
Vermont Department of Health 61
Janssen Resources
FDA Janssen COVID-19 Vaccine Website - Includes Fact Sheets, FAQs, Regulatory information and translations:https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/janssen-covid-19-vaccine
Manufacturer Website: https://www.janssencovid19vaccine.com
CDC Website - full of vaccine specific tools and resources: https://www.cdc.gov/vaccines/covid-19/info-by-product/janssen/index.html
Storage Summary:https://www.cdc.gov/vaccines/covid-19/info-by-product/janssen/downloads/janssen-storage-handling-summary.pdf
Preparation Summary:https://www.cdc.gov/vaccines/covid-19/info-by-product/janssen/downloads/Janssen-Prep-and-Admin-Summary.pdf
Standing Orders: https://www.cdc.gov/vaccines/covid-19/info-by-product/janssen/downloads/Janssen-Standing-Orders.pdf
